About this trial
The aim of this study is to explore the quality of life of cancer patients, in particular women operated on breast cancer, throughout their care journey, taking into account their access to supportive oncological care within and outside the establishment care.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Woman with histologically confirmed invasive breast cancer for whom surgery is scheduled
Age> 18 years old
Performance status ECOG <2
Patient speaking and understanding French and able to complete questionnaires
Disqualifiers
male
Patient with metastatic breast cancer
Patient with bilateral breast cancer
History of cancer of less than 5 years
Trial population
Women patient with breast cancer
Trial design
Case-control
Prospective
Treatments tested in this trial
Quality of life questionnaires
BehavioralDifferent quality of life questionnaires : FACT-B, EORTC QLQ-C30, QIC, BRIEF COPE, HADS, QSSS-C
Treatment groups
Trial outcomes
Primary outcomes
Quality of life questionnaire : FACT-B
Functional Assessment of Cancer Therapy-breast : 27 items about physical well-being, family well-being, emotional and functional well-being. The quotation is between 0 "not at all" and 4 "verry much". The total score is between 0 and 148. The higher the scores, the higher the QoL and the various well-being.
Quality of life questionnaire : EORTC QLQ-C30
30 items for all patient suffering from cancer. The answer of each question is between 1 "not at all" and 4 "very much"
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Ramsay Générale de Santé
Lead sponsor
European Clinical Trial Experts Network
Collaborator